Profile data is unavailable for this security.
About the company
NovaBay Pharmaceuticals, Inc. develops and sells scientifically created and clinically proven eyecare and wound care products. Its product, Avenova Antimicrobial Lid and Lash Solution, has antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. It offers a portfolio of products for each step of the standard at home treatment regimen, including the Avenova Eye Health Support antioxidant-rich oral supplement, Avenova Lubricating Eye Drops for instant relief, NovaWipes by Avenova, Avenova Warm Eye Compress to soothe the eyes, and the i-Chek by Avenova to monitor physical eyelid health. It also manufactures and sells its proprietary form of hypochlorous acid for the wound care market with its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers and other injuries.
- Revenue in USD (TTM)14.73m
- Net income in USD-16.70m
- Incorporated2010
- Employees24.00
- LocationNovaBay Pharmaceuticals Inc2000 Powell St Ste 1150EMERYVILLE 94608-1804United StatesUSA
- Phone+1 (510) 899-8800
- Fax+1 (510) 225-0371
- Websitehttps://novabay.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cyclacel Pharmaceuticals Inc | 420.00k | -22.76m | 3.03m | 12.00 | -- | 3.61 | -- | 7.21 | -26.72 | -26.72 | 0.4924 | 0.5732 | 0.0228 | -- | 0.1106 | -- | -122.40 | -57.58 | -212.95 | -69.81 | -- | -- | -5,370.24 | -18,789.29 | -- | -170.83 | 0.00 | -- | -- | 22.87 | -6.34 | -- | -31.23 | -- |
| Axim Biotechnologies Inc | 39.77k | -8.06m | 3.06m | 6.00 | -- | -- | -- | 76.87 | -0.0366 | -0.0366 | 0.0001 | -0.0311 | 0.0095 | -- | -- | 6,628.33 | -193.43 | -154.34 | -- | -390.73 | -- | -- | -20,265.75 | -36,362.71 | -- | -0.62 | -- | -- | 345.05 | -27.38 | -29.10 | -- | -- | -- |
| Clever Leaves Holdings Inc | 17.42m | -19.80m | 3.12m | 296.00 | -- | 0.1270 | -- | 0.1793 | -12.57 | -11.38 | 11.11 | 14.02 | 0.418 | 1.69 | 11.03 | 58,841.21 | -47.51 | -23.20 | -58.14 | -26.55 | 37.64 | -- | -113.66 | -207.52 | 1.63 | -3.70 | 0.0479 | -- | 6.14 | -- | 47.63 | -- | -- | -- |
| Applied DNA Sciences Inc | 9.00m | -7.29m | 3.13m | 53.00 | -- | 0.5857 | -- | 0.3482 | -10.91 | -10.91 | 13.56 | 6.20 | 0.5956 | 13.13 | 3.99 | 169,733.00 | -48.39 | -88.57 | -59.91 | -121.91 | 37.65 | 44.35 | -81.25 | -113.26 | 1.63 | -- | 0.00 | -- | -26.43 | 27.92 | -18.73 | -- | 33.80 | -- |
| Optimus Healthcare Services Inc | 1.27m | -7.79m | 3.20m | 17.00 | -- | -- | -- | 2.53 | -0.1948 | -0.1948 | 0.0317 | -0.1291 | 0.2595 | -- | 2.16 | 74,453.53 | -159.79 | -- | -2,228.37 | -- | 77.90 | -- | -615.77 | -- | 0.1525 | -15.41 | 21.18 | -- | -- | -- | -- | -- | -- | -- |
| AgriFORCE Growing Systems Ltd | 16.28k | -11.73m | 3.26m | 7.00 | -- | 0.0985 | -- | 200.23 | -14.14 | -14.14 | 0.014 | 1.47 | 0.0008 | -- | 0.408 | 2,325.71 | -59.84 | -78.95 | -84.37 | -109.86 | 16.58 | -- | -72,071.25 | -243,182.50 | 0.6922 | -1.39 | 0.3253 | -- | -- | -- | 8.85 | -- | 48.61 | -- |
| NovaBay Pharmaceuticals Inc | 14.73m | -16.70m | 3.28m | 24.00 | -- | 0.7492 | -- | 0.2228 | -3.82 | -3.82 | 3.50 | 0.2951 | 1.16 | 2.16 | 10.78 | 613,583.30 | -75.81 | -61.51 | -114.10 | -83.89 | 53.61 | 59.99 | -65.46 | -86.47 | 0.9998 | -- | 0.2555 | -- | 2.24 | 3.32 | -2.66 | -- | -15.46 | -- |
| Yield10 Bioscience Inc | 60.00k | -14.46m | 3.31m | 29.00 | -- | -- | -- | 55.15 | -50.04 | -50.04 | 0.1815 | -4.95 | 0.01 | -- | 4.00 | 2,068.97 | -241.08 | -91.26 | -524.02 | -108.09 | -- | -- | -24,091.67 | -2,279.74 | -- | -- | -- | -- | -86.67 | -35.94 | -6.55 | -- | 1.84 | -- |
| GB Sciences Inc | 0.00 | -4.03m | 3.33m | 3.00 | -- | -- | -- | -- | -0.0105 | -0.0105 | 0.00 | -0.0119 | 0.00 | -- | -- | 0.00 | -255.86 | -49.16 | -- | -131.40 | -- | 6.03 | -- | -995.19 | -- | -8.63 | -- | -- | -- | -- | -2,715.25 | -- | -60.82 | -- |
| Kiromic Biopharma Inc | 0.00 | -24.99m | 3.34m | 31.00 | -- | -- | -- | -- | -29.21 | -29.21 | 0.00 | -3.81 | 0.00 | -- | -- | 0.00 | -171.18 | -161.49 | -- | -213.01 | -- | -- | -- | -- | -- | -15.69 | 1.87 | -- | -- | -- | -35.90 | -- | 177.42 | -- |
| Navidea Biopharmaceuticals Inc | 610.00 | -8.81m | 3.50m | 11.00 | -- | -- | -- | 5,742.55 | -0.2086 | -0.0547 | 0.00001 | -0.0327 | 0.0001 | 0.1529 | 0.0066 | 55.45 | -143.97 | -169.68 | -- | -753.52 | -8,103.28 | 91.34 | -1,411,062.00 | -1,938.53 | 0.5066 | -- | -- | -- | -87.65 | -48.49 | -46.75 | -- | 63.23 | -- |
| Livewire Ergogenics Inc | 67.98k | -1.09m | 3.53m | 1.00 | -- | -- | -- | 51.99 | -0.0061 | -0.0061 | 0.0003 | -0.0022 | 0.1979 | 1.74 | 2.86 | 67,980.00 | -317.45 | -- | -- | -- | -113.70 | -- | -1,604.38 | -- | 0.1248 | -2.13 | -- | -- | 68.58 | -- | -3.64 | -- | -- | -- |
| ENDRA Life Sciences Inc | 0.00 | -10.06m | 3.56m | 21.00 | -- | 0.5925 | -- | -- | -1.93 | -1.93 | 0.00 | 0.5447 | 0.00 | -- | -- | 0.00 | -125.53 | -132.00 | -149.91 | -157.28 | -- | -- | -- | -- | -- | -- | 0.005 | -- | -- | -- | 23.67 | -- | -19.46 | -- |
Data as of May 07 2024. Currency figures normalised to NovaBay Pharmaceuticals Inc's reporting currency: US Dollar USD
3.88%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Armistice Capital LLCas of 31 Dec 2023 | 718.77k | 2.39% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 155.52k | 0.52% |
| Altium Capital Management LPas of 31 Dec 2023 | 67.46k | 0.22% |
| Virtu Americas LLCas of 31 Dec 2023 | 64.83k | 0.22% |
| Hudson Bay Capital Management LPas of 31 Dec 2023 | 54.00k | 0.18% |
| Citadel Securities LLCas of 31 Dec 2023 | 36.66k | 0.12% |
| Geode Capital Management LLCas of 31 Dec 2023 | 25.06k | 0.08% |
| HRT Financial LLCas of 31 Dec 2023 | 16.89k | 0.06% |
| Two Sigma Securities LLCas of 31 Dec 2023 | 15.96k | 0.05% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 13.71k | 0.05% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
